These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 19196235)

  • 1. Emerging diuretics for the treatment of heart failure.
    Sedghi Y; Gaddam KK; Ventura HO
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):195-204. PubMed ID: 19196235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective.
    Kazory A; Ross EA
    Circulation; 2008 Feb; 117(7):975-83. PubMed ID: 18285578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic treatment for the sodium retention of congestive heart failure.
    Cody RJ; Kubo SH; Pickworth KK
    Arch Intern Med; 1994 Sep; 154(17):1905-14. PubMed ID: 8074594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic usage in heart failure: a continuing conundrum in 2005.
    Gupta S; Neyses L
    Eur Heart J; 2005 Apr; 26(7):644-9. PubMed ID: 15734765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of vasopressin receptor antagonists in heart failure resulting in hospitalization.
    De Luca L; Orlandi C; Udelson JE; Fedele F; Gheorghiade M
    Am J Cardiol; 2005 Dec; 96(12A):24L-33L. PubMed ID: 16399090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.
    Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic use in heart failure and outcomes.
    von Lueder TG; Atar D; Krum H
    Clin Pharmacol Ther; 2013 Oct; 94(4):490-8. PubMed ID: 23852396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conivaptan Yamanouchi.
    Doggrell SA
    Curr Opin Investig Drugs; 2005 Mar; 6(3):317-26. PubMed ID: 15816509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiopathological bases in the treatment of water-salt retention in congestive heart failure].
    Agnoli GC
    Arch Patol Clin Med; 1970 Nov; 46(4):269-93. PubMed ID: 16548116
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond diuretics: management of volume overload in acute heart failure syndromes.
    Hill JA; Yancy CW; Abraham WT
    Am J Med; 2006 Dec; 119(12 Suppl 1):S37-44. PubMed ID: 17113399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolvaptan (Otsuka).
    Doggrell SA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):977-83. PubMed ID: 15503654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diuretic in chronic cardiac failure: a clumsy partner].
    Rocca C
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):599-606. PubMed ID: 16878721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of diuretics in the treatment of heart failure in the elderly.
    Sica DA; Gehr TW; Frishman WH
    Clin Geriatr Med; 2007 Feb; 23(1):107-21. PubMed ID: 17126757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical applications of intravenous diuretic therapy in decompensated heart failure.
    Cleland JG; Coletta A; Witte K
    Am J Med; 2006 Dec; 119(12 Suppl 1):S26-36. PubMed ID: 17113397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin and vasopressin receptor antagonists in heart failure.
    Oghlakian G; Klapholz M
    Cardiol Rev; 2009; 17(1):10-5. PubMed ID: 19092365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of diuretics in congestive heart failure: renal effects].
    Timio M; Saronio P; Venanzi S; Bellomo G; Timio F
    G Ital Nefrol; 2006; 23 Suppl 34():S44-6. PubMed ID: 16633994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conivaptan: a selective vasopressin antagonist for the treatment of heart failure.
    Schwarz ER; Sanghi P
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):17-23. PubMed ID: 16375624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart failure. Can vasopressin antagonists improve the prognosis?].
    MMW Fortschr Med; 2003 Nov; 145(48):10. PubMed ID: 14724989
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of tolvaptan in acute decompensated heart failure.
    Ho JE; Teerlink JR
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):601-8. PubMed ID: 18510477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of peripheral ultrafiltration in the management of acute decompensated heart failure.
    Andrade JG; Stadnick E; Virani SA
    Blood Purif; 2010; 29(2):177-82. PubMed ID: 20093824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.